The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients' preferences for adjuvant osimertinib in non–small cell lung cancer (NSCLC) after complete surgical resection: What makes it worth it to patients? (PATT)—The Roswell Park (RP) Comprehensive Cancer Center experience.
 
Angel Mier-Hicks
No Relationships to Disclose
 
Kristopher Attwood
No Relationships to Disclose
 
Kayla Catalfamo
No Relationships to Disclose
 
Prantesh Jain
No Relationships to Disclose
 
Hongbin Chen
No Relationships to Disclose
 
Edwin Yau
No Relationships to Disclose
 
Amy P. Early
No Relationships to Disclose
 
Grace K. Dy
Consulting or Advisory Role - AstraZeneca; Lilly; Mirati Therapeutics
Research Funding - AMGEN (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Tesaro (Inst)